Make Genomic
Evidence Actionable
Simplify complex genetic data into actionable insights for patient diagnosis and precision medicine development with Genomenon's software, data, and services.
ACMG Secondary Findings
Now in Mastermind
Genomenon Targets WGS Analysis Costs with Curated ACMG Secondary Findings
The World's Most Comprehensive
Source of Genomic Evidence
Genomenon's Mastermind Genomic Intelligence Platform
Genomenon's
On Demand
Curation Experts
Genomenon now offers evidence curation and variant classification services, accessed on-demand, or as a longer-term extension of your own team of genetic scientists.
Navigating Genomic Data
Genomic data is growing rapidly, but finding clinically relevant insights remains difficult. The complexity and inconsistency across resources slow down diagnosis and limit the potential of precision medicine.
Genomenon solves this by organizing the world’s genomic knowledge into powerful platforms that connect clinicians, researchers and precision therapeutic developers with the most relevant evidence. Through our advanced AI technology and team of scientific experts, we are unlocking previously buried genomic data in clinical literature into actionable insights.
What We Offer
Software
Explore Genomenon's platforms for germline and somatic variant interpretation
Mastermind Genomic Intelligence Platform
Access actionable insights from genomic literature on more than 27 million variants, as well as curated germline variant content to aid clinical decision making.
Cancer Knowledgebase (CKB)
Genomenon's Cancer Knowledgebase is used to interpret cancer variants, connecting them to therapies and clinical trials.
Services
Genomenon's expert team of genetic scientists provides tailored consulting services to support your genomic projects. From custom variant analysis to clinical trial support and regulatory guidance, we ensure you have the expert insights needed for your specific genomic challenges.
Data
Gain access to Genomenon's expansive, constantly updated database of curated genomic information. This resource offers a wealth of gene-disease associations and variant data, whether indexed or curated, delivered via an API or flat files for direct integration into your tertiary analytic platform.
Trusted by Industry Leaders Including
Driving Insights and Discovery across Clinical Diagnostics and Precision Therapeutics
Never Miss a
Diagnosis
Genomenon accelerates variant interpretation and increases your diagnostic yield with rapid genomic literature search and comprehensive genomic insights.
Inform Your Drug Program
Partner with Genomenon to gain rapid, real-world evidence insights that de-risk your precision medicine program from discovery to commercialization, supporting your genetic research.
The Race to Curate
the Human Genome
Genomenon's goal is to unlock the full potential of genomic data by curating the entire human genome, transforming it into actionable knowledge that can revolutionize healthcare and genetic disease research.
How can Genomenon help you?
Fill out this form to get in touch with our team.
Helping to Make an Impact
Real-World Evidence for Precision Therapeutics
WE WILL DISCUSS TWO CASE STUDIES:
- Rare Disease Use Case: Diagnostic Impact through Curation
- Cancer Use Case: AI-Driven Insights for Drug Discovery
- Broader Implications: Enabling Precision Therapeutics with Patient-Derived RWE
Unraveling Genomic Complexity: Expert Insights Variant Curation Interpretation
YOU WILL LEARN:
- The role of AI in curation & interpretation
- How our curation team systematically records discrete evidence in order to apply criteria
- How our product quality team reviews a large project to ensure scientific accuracy
Developing Treatments for Rare Disease
YOU WILL GAIN RARE INSIGHTS INTO:
- How rare disease companies decide which orphan drug programs to pursue
- How to foster stronger collaboration among drug developers, KOLs, patient advocates, and other stakeholders
- How we can work together to help end the diagnostic odyssey for rare disease patients
- A vision for the future of orphan drug development and patient advocacy
The End of VUS? Impact on Diagnosis and Treatment of Rare Diseases
WE WILL DISCUSS:
- The impact of VUS on diagnosis and treatment
- Current and future strategies to reduce the burden of VUS
- The likelihood of eliminating VUS and what it would mean if we did
- A vision for the future of rare disease diagnostics
Medium length heading goes here
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Talk to a Genomenon expert.
